SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / January 2, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar”) today announced ...
Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The ...
Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel ...
Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...
Data demonstrate clinical translation of VOWST mechanisms of action in both first and multiply recurrent CDI patientsSeres MbTx® platform ...
Even with correct antibiotic doses, some bacterial infections return because persister cells survive treatment by entering ...
University of Otago scientists are harnessing the power of peptides—the body's own tiny protein molecules—for a spray to help ...
Spotify was hit with a class action lawsuit in federal court accusing the streaming giant of disguising its controversial Discovery Mode, which recommends songs to users in certain algorithmic mixes ...
A class action lawsuit accuses Spotify of engaging in “payola” to allow record labels to secretly promote their artists in the streaming service’s Discovery Mode. The lawsuit, filed Tuesday in a ...
ABSTRACT: Tetracyclines are broad-spectrum antibiotics that stop bacteria from producing proteins by blocking peptide elongation and aminoacyl-tRNA attachment, by reversibly binding to the 30S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback